Lupin, Inc.

Lupin Atlantis Holdings Sa

Majid Bashir Sayyed

Rajender Kumar Kamboj

Venkata Poornapragnacharyulu Palle

Sanjeev Anant Kulkarni

Manojkumar Ramprasad Shukla

Neelima Sinha

Sudershan Kumar Arora

Anil Kashiram Hajare

Prathap Sreedharan Nair

Mahadeo Bhaskar Tryambake

Chetan Sanjay Pawar

Navnath Bajirao Walke

Ramesh Dattatraya Phadtare

Vinod Dinkar Chaudhari

Ganesh Navinchandra Gote

Rajan Goel

Sarde Gangaram Ankush

Pachpute Dilip Vipul

Sai Kumar Chakka

Azmi Reddy

Pravin Patil

K H Sreedhara Swamy

Compounds of Formula (I) along with processes for their preparation that are useful for treating, managing and/or lessening the diseases, disorders, syndromes or conditions associated with the modulation of calcium sensing (CaSR) receptors. Methods of treating, managing and/or lessening the diseases, disorders, syndromes or conditions associated with the modulation of calcium sensing (CaSR) receptors of Formula (I). 

Benzo [B] [1,4] oxazin derivatives as calcium sensing receptor modulators

Substituted morpholines as modulators for the calcium sensing receptor

The present invention is related to novel compounds of the general formula A, their tautomeric forms, their stereoisomers, their pharmaceutically acceptable salts, pharmaceutical compositions containing them, methods of making of the above compounds, and their use as Dipeptidyl Peptidase-IV (DPP-IV) Inhibitors, which are useful in the treatment or prevention of diseases particularly Type II diabetes, other complications related to diabetes and other pathogenic conditions in which DPP IV enzyme is involved.

Compounds as dipeptidyl peptidase IV (DPP IV) inhibitors

Growing community of inventors

Maharashtra, India

Majid Bashir Sayyed